Standard BioTools Inc.LABNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank79
3Y CAGR+82.9%
5Y CAGR+12.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+82.9%/yr
vs -25.4%/yr prior
5Y CAGR
+12.8%/yr
Recent acceleration
Acceleration
+108.4pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.72 | +61.8% |
| 2024 | 3.54 | +115.1% |
| 2023 | 1.65 | +75.9% |
| 2022 | 0.94 | -58.9% |
| 2021 | 2.28 | -27.3% |
| 2020 | 3.13 | +57.9% |
| 2019 | 1.98 | -34.5% |
| 2018 | 3.03 | +58.8% |
| 2017 | 1.91 | -5.8% |
| 2016 | 2.02 | - |